Dr. Barry Dworkin

FDA approval Xarelto for stroke prevention in atrial fibrillation patients questioned

Madely Health Headlines Commentary for September 14, 2011

Source:

FDA Panel Backs Xarelto for Stroke Prevention

 

Reference

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

 

Related posts:

  1. New stroke-prevention drug may replace warfarin for people with atrial fibrillation
  2. New blood thinners add value to stroke prevention and quality of life
  3. Silent atrial fibrillation a cause for strokes:study
  4. Medications seem to work as well as stents for people with stable heart disease